Update on botulinum toxin

被引:21
|
作者
Flynn, Timothy Corcoran [1 ]
机构
[1] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA
关键词
D O I
10.1016/j.sder.2006.06.003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Botulinum toxin for facial enhancement is currently the most popular aesthetic procedure performed in the United States. New developments have occurred within the last few years. Patients prefer having multiple areas of the upper face treated which increases patient satisfaction. Treatment of the forehead is now being accomplished with fewer units of botulinum toxin. This helps preserve the natural look of some movement of the forehead. Men require more units of botulinum toxin than women. Combination therapy using botulinum toxin along with lasers or filler substances is ideal. Aesthetic medicine knowledge has progressed, contributing a greater understanding of botulinum treatment for advanced areas of the face. The orbicularis oris, mentalis, and depressor anguli oris are now routinely treated and help improve overall facial appearance. Other forms of botulinum toxins (additional type A or type B toxins) are available, each with advantages and disadvantages.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [31] A succinct review of botulinum toxin in dermatology; update of cosmetic and noncosmetic use
    Feily, Amir
    Fallahi, Hamidreza
    Zandian, Dana
    Kalantar, Hossein
    JOURNAL OF COSMETIC DERMATOLOGY, 2011, 10 (01) : 58 - 67
  • [32] Botulinum toxin as part of an integrative therapeutic approach. Update 2009
    Schroeder, A. S.
    Huss, K.
    Berweck, S.
    Heinen, F.
    MONATSSCHRIFT KINDERHEILKUNDE, 2009, 157 (11) : 1120 - +
  • [33] An update on the treatment of detrusor-sphincter dyssynergia with botulinum toxin type A
    Schurch, B
    Schmid, DM
    Knapp, PA
    EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 : S83 - S89
  • [34] Update on intraprostatic botulinum toxin injections in the treatment of benign prostatic hyperplasia
    Renard, Olivier
    Ballanger, Philippe
    Robert, Gregoire
    PROGRES EN UROLOGIE, 2010, 20 (03): : F90 - F95
  • [35] Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update
    Cruz, F
    Silva, C
    CURRENT OPINION IN UROLOGY, 2004, 14 (06) : 329 - 334
  • [37] BOTULINUM TOXIN
    DAVIES, DG
    DHILLON, RS
    BRITISH MEDICAL JOURNAL, 1989, 298 (6672): : 522 - 522
  • [38] BOTULINUM TOXIN
    TSUI, JKC
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1989, 2 (04): : 501 - 503
  • [39] BOTULINUM TOXIN
    LEES, AJ
    BRITISH MEDICAL JOURNAL, 1992, 305 (6863): : 1169 - 1170
  • [40] Botulinum toxin
    Truong, D.
    Boholega, S.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S193 - S193